These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33499762)

  • 21. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B; Luoma JB; Bathje GJ; Rhea J; Narloch VF
    Harm Reduct J; 2021 Apr; 18(1):40. PubMed ID: 33827588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
    Greenway KT; Garel N; Jerome L; Feduccia AA
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):655-670. PubMed ID: 32478631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
    Holoyda B
    Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
    Yaden DB; Earp D; Graziosi M; Friedman-Wheeler D; Luoma JB; Johnson MW
    Front Psychol; 2022; 13():873279. PubMed ID: 35677124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D; Barrett FS; Vandrey R
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature.
    Golden TL; Magsamen S; Sandu CC; Lin S; Roebuck GM; Shi KM; Barrett FS
    Curr Top Behav Neurosci; 2022; 56():35-70. PubMed ID: 35138585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.
    Sekula AD; Downey L; Puspanathan P
    Front Psychol; 2022; 13():813746. PubMed ID: 35310225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A; Suppes T; Haug NA
    Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How Psychedelic-Assisted Treatment Works in the Bayesian Brain.
    Villiger D
    Front Psychiatry; 2022; 13():812180. PubMed ID: 35360137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychedelics and the essential importance of context.
    Carhart-Harris RL; Roseman L; Haijen E; Erritzoe D; Watts R; Branchi I; Kaelen M
    J Psychopharmacol; 2018 Jul; 32(7):725-731. PubMed ID: 29446697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
    Gardner J; Carter A; O'Brien K; Seear K
    Int J Drug Policy; 2019 Aug; 70():94-98. PubMed ID: 31136924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. With great power comes great vulnerability: an ethical analysis of psychedelics' therapeutic mechanisms proposed by the REBUS hypothesis.
    Villiger D; Trachsel M
    J Med Ethics; 2023 Nov; 49(12):826-832. PubMed ID: 37045591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Past and Future of Psychedelic Science: An Introduction to This Issue.
    Doblin RE; Christiansen M; Jerome L; Burge B
    J Psychoactive Drugs; 2019; 51(2):93-97. PubMed ID: 31132970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology.
    Hartogsohn I
    J Psychopharmacol; 2016 Dec; 30(12):1259-1267. PubMed ID: 27852960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.
    Rieser NM; Herdener M; Preller KH
    Curr Top Behav Neurosci; 2022; 56():187-211. PubMed ID: 34910289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tripping on nothing: placebo psychedelics and contextual factors.
    Olson JA; Suissa-Rocheleau L; Lifshitz M; Raz A; Veissière SPL
    Psychopharmacology (Berl); 2020 May; 237(5):1371-1382. PubMed ID: 32144438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shamans, sacraments, and psychiatrists.
    Bravo G; Grob C
    J Psychoactive Drugs; 1989; 21(1):123-8. PubMed ID: 2656948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.